Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. finalizes acquisition of a portfolio of 11 fast-growing cardiometabolic products Corporate NewsBy adminJune 1, 2023
Rameda acquires exclusive rights for the distribution and marketing of “Physiomer” in Egypt Corporate NewsBy adminDecember 20, 2022
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. inaugurates a new high-precision water treatment station Corporate NewsBy adminAugust 21, 2022
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. joins the UN Global Compact, the world’s largest corporate sustainability initiative. Corporate NewsBy adminJune 20, 2022
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. commences the production of antiviral COVID-19 treatment, Molnupiravir Rameda Corporate NewsBy adminJune 17, 2022
